可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 臧益民,臧伟进,王晓明. 心力衰竭的病理生理机制及治疗概述[J].心脏杂志,2002,14(5):417-419.
[2]Tsutamoto T,Hisamage T,Wada A,et al. Interleukin-6 spillover in the perpheral circulation increases with the severity of heart failure and the high plasma level of interleukin6 is an important prognostic predictor in patients with congestive heart failure[J]. Am Coll Cardiol,1998,31:391-398.
[3]王晓明,李源,李惠芳,等. 心力衰竭患者血清中TNFα、IL-1及IL6的变化及培哚普利对其影响[J].心脏杂志,2002,14(4):318-322.
[4]Hakeyama K,Kagamiyama H,Simmons RL,et al.Tetrahydrobiopterin synthesis and inducible nitric oxide production in pulmonary artery smooth muscle[J]. Am J Physiol,1994,266:455-460.
[5]Finkel MS,Oddis CV,Jacob TD,et al.Negative inotropic effects of cytokines on the heart mediated by nitric oxide[J]. Science,1992,257:387-389.
[6]Meredith PA. Optimal closiny charaacteristics of the angiiotensin II receptor antaginist telmisartan[J]. Am J Cardiol,1999,84(2A):7K-12K.
[7]Kario K,Pickering T.Modification of hight blood pressure after myocardial infarction[J]. Med Clin Nor Amer,2000,84(1):1-21.